India to Kenya: Ifosfamide Export Trade Route

The India to Kenya Ifosfamide corridor is one of India's established pharmaceutical export routes, with 67 shipments documented worth a combined $94.7K USD. The route is dominated by VIVIORA LIFESCIENCES PRIVATE LIMITED , which alone accounts for roughly 34% of all export value, reflecting the consolidated nature of India's ifosfamide manufacturing sector.

Across 18 active suppliers, the average shipment value stands at $1.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with ifosfamide's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 34.5%, placing it at rank #3 among India's top ifosfamide export destinations globally.

On the import side, key buyers of Indian ifosfamide in Kenya include Ethiopian Pharmaceuticals Supply Ag , M/S NAIROBI ENTERPRISES LTD. , SALAMA PHARMACEUTICALS LIMITED and 19 others. Ethiopian Pharmaceuticals Supply Ag is the single largest importer with 2 shipments valued at $31.9K USD.

India's ifosfamide exports to Kenya are driven primarily by a handful of large-scale manufacturers. VIVIORA LIFESCIENCES PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 18 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VIVIORA LIFESCIENCES PRIVATE LIMITED , GETWELL PHARMACEUTICALS , UNITED BIOTECH PRIVATE LIMITED — together account for 63% of total trade value on this route. The average shipment value of $1.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma product-ifomid m 2g (ifosfamide f and fosfa 2g (ifosfamide for inj. usp with m , suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, Ethiopian Pharmaceuticals Supply Ag is the largest importer with 2 shipments worth $31.9K USD — representing 34% of all ifosfamide imports from India on this route. A total of 22 buyers are active on this corridor.